Trial Profile
Safety and efficacy of mitoxantrone liposomal (PLM60) in patients with advanced/refractory non-Hodgkin's lymphoma: A phase Ib open label randomised study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2018
Price :
$35
*
At a glance
- Drugs Mitoxantrone liposomal (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 28 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology